Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Milestone Pharmaceuticals Inc. (MIST) had Pre-Tax Profit Margin of -4078.78% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.55M |
|
$-63.06M |
|
-- |
|
$1.55M |
|
$63.69M |
|
$-62.14M |
|
$-0.92M |
|
$-63.06M |
|
$-63.06M |
|
$-63.06M |
|
$-63.06M |
|
$-63.06M |
|
$-63.06M |
|
$-62.14M |
|
$-62.03M |
|
83.88M |
|
83.88M |
|
$-0.75 |
|
$-0.75 |
|
| Balance Sheet Financials | |
$111.92M |
|
$0.51M |
|
$1.64M |
|
$113.56M |
|
$13.98M |
|
$57.19M |
|
$57.81M |
|
$71.79M |
|
$41.77M |
|
$41.77M |
|
$41.77M |
|
106.24M |
|
| Cash Flow Statement Financials | |
$-49.04M |
|
$11.25M |
|
$85.53M |
|
$25.31M |
|
$73.05M |
|
$47.73M |
|
$7.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.01 |
|
-- |
|
-- |
|
0.58 |
|
1.37 |
|
100.00% |
|
-4019.41% |
|
-4019.41% |
|
-4012.03% |
|
|
Pre-Tax Profit Margin |
-4078.78% |
-4078.78% |
|
$-49.34M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.48 |
|
753.61 |
|
-150.97% |
|
-150.97% |
|
-55.53% |
|
-63.72% |
|
$0.39 |
|
$-0.59 |
|
$-0.58 |
|